Global Glabridin (CAS 59870-68-7) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch"s in-depth investigation and research, the global Glabridin (CAS 59870-68-7) market size will reach 39.65 Million USD in 2025 and is projected to reach 63.92 Million USD by 2032, with a CAGR of 7.06% (2025-2032). Notably, the China Glabridin (CAS 59870-68-7) market has changed rapidly in the past few years. By 2025, China"s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Glabridin (CAS 59870-68-7) is a natural compound extracted from the root of licorice (Glycyrrhiza glabra) and is known for its various biological activities. This plant-derived substance is commonly used in cosmetics and skincare products due to its skin-brightening and anti-inflammatory properties. Glabridin inhibits tyrosinase, an enzyme involved in the production of melanin, making it a sought-after ingredient in formulations aiming to lighten hyperpigmentation and even out skin tone. Additionally, glabridin exhibits antioxidant effects, providing potential benefits for protecting the skin against oxidative stress. The compound has garnered attention in the cosmetic and pharmaceutical industries for its potential role in promoting skin health and addressing various dermatological concerns.

The major global  manufacturers of Glabridin (CAS 59870-68-7) include Sabinsa, Alchem International, MAFCO, Plamed Green Science Group, Xi"an Zhongying, Spring Autumn Biological, Huaian Brothers Biotechnology, Xi’an Tianye Biotech, SK Bioland, Maruzen Pharmaceuticals, Sunpure Extracts, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Glabridin (CAS 59870-68-7). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Glabridin (CAS 59870-68-7) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Glabridin (CAS 59870-68-7) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Glabridin (CAS 59870-68-7) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Glabridin (CAS 59870-68-7) Include:

Sabinsa

Alchem International

MAFCO

Plamed Green Science Group

Xi"an Zhongying

Spring Autumn Biological

Huaian Brothers Biotechnology

Xi’an Tianye Biotech

SK Bioland

Maruzen Pharmaceuticals

Sunpure Extracts

Glabridin (CAS 59870-68-7) Product Segment Include:

20% (HPLC)

40% (HPLC)

60% (HPLC)

90% (HPLC)

98% (HPLC)

Other

Glabridin (CAS 59870-68-7) Product Application Include:

Cosmetic

Pharmaceutical

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Glabridin (CAS 59870-68-7) Capacity and Production Analysis

Chapter 3: Global Glabridin (CAS 59870-68-7) Industry PESTEL Analysis

Chapter 4: Global Glabridin (CAS 59870-68-7) Industry Porter's Five Forces Analysis

Chapter 5: Global Glabridin (CAS 59870-68-7) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 6: Global Glabridin (CAS 59870-68-7) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 7: Global Glabridin (CAS 59870-68-7) Sales, Revenue, Price and Forecast by Product Type

Chapter 8: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 9: Industrial Chain Analysis, Glabridin (CAS 59870-68-7) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 10: Research Findings and Conclusion

Chapter 11: Methodology and Data Sources Show more